Skip to main content
13 April 2021
Last updated:
Tuesday 13 April 2021

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
  • Contact Us

Biosimilar medicine

generic copies of off patent biologic drugs that are similar but not exact copies of the original therapy

Developing biosimilar monoclonal antibodies will not be easy

Wednesday 23 March 2011
Interviewee/Contributor
Gabriele Schaffner-Dallmann
Organisation
Pharmatching GmbH
Antibody
Biosimilar medicine
Policy & Regulation
  • Read more about Developing biosimilar monoclonal antibodies will not be easy

EMA guidance on biosimilar monoclonal antibodies

Wednesday 12 January 2011
Interviewee/Contributor
Cecil Nick
Organisation
Parexel
Antibody
Biosimilar medicine
Policy & Regulation
  • Read more about EMA guidance on biosimilar monoclonal antibodies
Subscribe to Biosimilar medicine

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

René Hoet becomes CSO at Montis Biosciences
Wednesday March 31 2021
Pan Cancer T makes board appointments
Wednesday March 31 2021
Björn Englund appointed CEO at Opterion
Wednesday March 31 2021
Sven Zimmermann joins Inotrem
Wednesday March 31 2021
New director at Mission Therapeutics
Wednesday March 31 2021

© 2021 Evernow Publishing Ltd. Powered by Drupal.